Results
1 -
10 of
41
(Click
here to explore results)
- Drug Discovery for Leishmaniasis, Chapter 3 From Bench to Bedside: Development and Optimization of Clinical Therapies for Visceral Leishmaniasis. Fabiana Alves, Jean-Yves Gillon, Byron Arana, Thomas P. C. Dorlo
, 2018
, Pages 37-54
- Neglected Diseases and Drug Discovery, Chapter 6 Drugs for Kinetoplastid Diseases – Current Situation and Challenges. Simon L. Croft
, 2012
, Pages 134-158
- Drug Discovery for Leishmaniasis, Chapter 6 Omics and Their Impact on the Development of Chemotherapy Against Leishmania. Christopher Fernández-Prada, Isabel M. Vincent, Élodie Gazanion, Rubens L. Monte-Neto
, 2018
, Pages 101-129
- Carbohydrates in Drug Design and Discovery, Chapter 7 Synthetic Glycosylated Ether Glycerolipids as Anticancer Agents. Gilbert Arthur, Frank Schweizer, Makanjuola Ogunsina
, 2015
, Pages 151-179
- Computational Systems Pharmacology and Toxicology, CHAPTER 12 Chemical–Disease Category Linkage (CDCL): Computational Methods Linking Traditional Chinese Medicines and Western Therapeutics. Dale E. Johnson, Kit Wun Kathy Cheung
, 2017
, Pages 279-299
- Neurodegeneration: Metallostasis and Proteostasis, Chapter 9 The Role of Iron in Neurodegeneration. F. A. Zucca, F. A. Cupaioli, L. Zecca
, 2011
, Pages 174-211
- Drug Discovery for Leishmaniasis, Subject Index
, 2018
, Pages 396-402
- Drug Discovery for Leishmaniasis, I. Appraisal of Leishmaniasis Chemotherapy, Current Status and Pipeline StrategiesChapter 1 Leishmaniasis, Impact and Therapeutic Needs. Jorge Alvar, Byron Arana
, 2018
, Pages 1-23
- Drug Discovery for Leishmaniasis, Chapter 8 Medicinal Chemistry Strategies to Discover New Leishmanicidal Drugs. Ana Martinez, Carmen Gil
, 2018
, Pages 153-178
- Drug Discovery for Leishmaniasis, Chapter 2 Anti-leishmanial Drug Discovery: Past, Present and Future Perspectives. Charles E. Mowbray
, 2018
, Pages 24-36